Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anakinra in Heart Failure
NCT01300650Phase 2Completed
- Sponsor
- Virginia Commonwealth University
- Start
- Feb 2011
- Primary completion
- Aug 2011
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of anakinra in heart failure (HF), sponsored by Virginia Commonwealth University. Primary endpoints: Peak Oxygen Consumption at 14 days and Minute Ventilation/Carbon Dioxide Production Slope at 14 days. Started Feb 2011; status: completed.
02
Drugs
anakinra
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT01300650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01300650.